Beyang Therapeutics
AI-driven drug discovery company using its ExCEED molecular design platform
$30MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
AI-driven drug discovery company using its ExCEED molecular design platform
Developing the next generation of precision medicines by going beyond genomics.
Pitching Root Venture Partners? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room